• 1st longer term tirzepatide study (3 years)

  • Nov 14 2024
  • Length: 45 mins
  • Podcast

1st longer term tirzepatide study (3 years)

  • Summary

  • Drs. Karl and Spencer discuss the brand new 3 year study of tirzepatide in those with prediabetes along with a discussion on semaglutide treating osteoarthritis.

    Learn:

    • If people lose weight and keep it off with tirzepatide
    • How many people regain weight after stopping the medicine
    • Long-term side effects
    • If semaglutide helps with osteoarthritis

    Click here to read the tirzepatide study

    Click here to read the semaglutide study

    Show More Show Less

What listeners say about 1st longer term tirzepatide study (3 years)

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.